Jason Cavalier

Insider Reports History

Location
Watertown, MA
Signature
/s/ Jason Cavalier
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Cavalier:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lyra Therapeutics, Inc. Chief Financial Officer Common Stock 518,547 $1,744,392 $3.36 06 Jan 2026 Direct

Insider Reports Filed by Jason Cavalier

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LYRA Lyra Therapeutics, Inc. 06 Jan 2026 1 -$2,587 4 Chief Financial Officer 08 Jan 2026, 16:30
LYRA Lyra Therapeutics, Inc. 10 Jul 2025 1 -$6,094 4 Chief Financial Officer 14 Jul 2025, 21:27
LYRA Lyra Therapeutics, Inc. 16 Oct 2024 1 $0 4 Chief Financial Officer 18 Oct 2024, 16:05
LYRA Lyra Therapeutics, Inc. 30 Jan 2024 1 $0 4 Chief Financial Officer 01 Feb 2024, 16:15
LYRA Lyra Therapeutics, Inc. 08 Jan 2024 1 $0 4 Chief Financial Officer 10 Jan 2025, 16:15
LYRA Lyra Therapeutics, Inc. 31 Jan 2023 1 $0 4 Chief Financial Officer 02 Feb 2023, 16:11
LYRA Lyra Therapeutics, Inc. 12 Feb 2022 1 $0 4 Chief Financial Officer 15 Feb 2022, 20:30
LYRA Lyra Therapeutics, Inc. 13 Sep 2021 1 $0 4 Chief Financial Officer 15 Sep 2021, 17:44
LYRA Lyra Therapeutics, Inc. 13 Sep 2021 0 $0 3 Chief Financial Officer 15 Sep 2021, 17:40